Understanding the genetics of gene regulation provides information on the cellular mechanisms 41 through which genetic variation influences complex traits. Expression quantitative trait loci, or 42 eQTLs, are enriched for polymorphisms that have been found to be associated with disease risk. 43 While most analyses of human data has focused on regulation of expression by nearby variants 44 (cis-eQTLs), distal or trans-eQTLs may have broader effects on the transcriptome and important 45 phenotypic consequences, necessitating a comprehensive study of the effects of genetic variants 46 on distal gene transcription levels. In this work, we identify trans-eQTLs in the Genotype Tissue 47 Expression (GTEx) project data 1 , consisting of 449 individuals with RNA-sequencing data 48 across 44 tissue types. We find 81 genes with a trans-eQTL in at least one tissue, and we 49 demonstrate that trans-eQTLs are more likely than cis-eQTLs to have effects specific to a single 50 tissue. We evaluate the genomic and functional properties of trans-eQTL variants, identifying 51 strong enrichment in enhancer elements and Piwi-interacting RNA clusters. Finally, we describe 52 three tissue-specific regulatory loci underlying relevant disease associations: 9q22 in thyroid that 53 has a role in thyroid cancer, 5q31 in skeletal muscle, and a previously reported master regulator 54 near KLF14 in adipose. These analyses provide a comprehensive characterization of trans-eQTLs 55 across human tissues, which contribute to an improved understanding of the tissue-specific 56 cellular mechanisms of regulatory genetic variation. 57 Introduction 58
. Trans-eQTLs across 44 diverse tissues in the GTEx data. (a) The number of trans-eGenes in all the tissues at three FDR thresholds, ordered with decreasing number of expressed genes. The x-axis labels include (number of expressed gene, number of samples) for each tissue. (b) Distribution of the number of tissues having MetaTissue m-value greater than 0.5 for the top variant for each trans-eGene at FDR ≤ 0.5 and each randomly selected cis-eGenes (also FDR ≤ 0.5). cis-eGenes were matched for discovery tissue distribution to the trans-eGenes. Shown for genes with meta-analysis p-value ≤ 0.01. (c) Hierarchical agglomerative clustering of trans-eGenes (FDR ≤ 0.5) using a distance metric of (1 − Spearman correlation) of MetaTissue effect sizes over all genes observed in both tissues. (d) An example of a trans-eQTL (rs7683255 − NUDT13) identified in skin -sun-exposed (FDR ≤ 0.1, P ≤ 1.1 x 10 -10 ) that has a global effect across tissues. The lines represent 95% confidence interval of the effect size. (e) An example of a trans-eQTL (rs60413914 − RMDN3) identified in brain putamen (FDR ≤ 0.1, P ≤ 1.2 x 10 -13 ) that has an effect in all five brain tissues tested but shows little effect in other tissues. (f) An example of a trans-eQTL (rs758335 − RPL3) identified in pancreas (FDR ≤ 0.1, P ≤ 2.2 x 10 -16 ) that has a tissue-specific effect.
We also investigated long range eQTLs where the variant lies on the same chromosome as the 120 target gene but is not local. We performed association mapping between each gene and variant 121 on the same chromosome and we identified 291 intra-chromosomal distal eQTLs (≥ 5 Mb 122 between gene and variant; FDR ≤ 0.1), including 46 eGenes and 247 eVariants (Extended Data 123 Table 1 ). Further, investigated whether intra-chromosomal distal QTLs acted in cis or trans using 124 a statistical model to quantify evidence for allele-specific expression (ASE), as cis regulation 125 would induce allelic imbalance in gene expression levels for cis-eVariant heterozygotes 3, 18 Genome wide
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Any approach Each tissue with non-zero values in one or more of the restricted approaches is included in the rows with the total on the final row; the columns include the number of samples for that tissue, followed by the number of unique trans-eGenes and trans-eVariants identified in the genome-wide tests, and tests restricted to the LD-pruned, cis-eQTL, and trait associated variants, followed by the number of unique trans-eGenes and trans-eVariants identified by any of the four approaches. ( Fig. 3d , Extended Data Fig. 10 ). Despite the substantial changes to gene expression levels in 288 cancer tissue, we replicated both trans-eQTL associations from GTEx in TCGA data, TMEM253 289 (GTEx P ≤ 1.2 x 10 -4 , FDR ≤ 0.034) and ARFGEF3 (GTEx P ≤ 1.1 x 10 -5 , FDR ≤ 0.0097).
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Among 15 variants associated with TMEM253, rs10115216 was also associated in cis with 291 FOXE1 (P ≤ 9.3 x 10 -3 , FDR ≤ 0.043) and rs6586 in cis with C9orf156 (FDR ≤ 3.0 x 10 -13 ).
292
These results demonstrate replication of both the broad impact of the 9q22 locus and particular 293 target genes in thyroid tumor tissue. For every gene, absolute correlation was sorted in decreasing order. The correlation of FOXE1 with the 5th, 6th, 7th, and 8th PEER factors was significantly higher than the correlation of random genes at those rank ordered PEER factors (empirical P ≤ 0.05). (c) P-value histogram of associations between 19 variants in the 9q22 locus and all genes in GTEx thyroid gene expression levels, compared to 19 random variants from the same chromosome. (d) P-value histogram of associations between 23 variants in the 9q22 locus and all genes in TCGA thyroid tumor expression data, compared to 23 random variants from the same chromosome.
Trait-associated variants in skeletal muscle near interferon regulatory factor IRF-1 296 In skeletal muscle, two linked variants in the 5q31 locus (rs2706381 and rs1012793, R 2 = 0.84)
297
were associated in trans with the expression of immune response genes PSME1 (P ≤ 9.8 x 10 -12 ), 298 and ARTD10 (P ≤ 8.3 x 10 -10 ). A third variant on the same locus (R 2 = 0.50), rs12659708, also 299 showed significant association with ARTD10 (P ≤ 4.8 x 10 -14 ) and moderate association with 300 PSME1 (P ≤ 1.6 x 10 -7 ). These variants were moderately associated with numerous genes in Table 4 ). The two linked variants rs2706381 and rs1012793 306 were also significantly associated with circulating fibrinogen levels in a GWAS 52 . Fibrinogen To explore cellular mechanisms underlying these effects, we evaluated cis regulatory 311 associations for each variant. Rs1012793 and rs12659708 appeared as cis-eVariants associated 312 with IRF-1, and rs1012793 was associated with SLC22A4 (FDR ≤ 0.05). However, the directions 313 of effect between cis and trans targets were only consistent for IRF-1 (Fig. 4a) . The association 314 statistics in this region were also highly concordant for IRF-1 (cis-eGene) and PSME1 (trans-315 eGene), (Fig. 4b) , quantified using colocalization analysis 49 , which produced posterior 316 probabilities greater than 0.97 that the same causal variant regulates IRF-1 and each of PSME1 and ARTD10 were also identified as potential IRF-1 targets in primary human monocytes 65 .
321
Together, these results suggest cis regulatory loci affecting IRF-1 are regulators of the IFN 322 responsive inflammatory processes involving genes including PSME1 and ARTD10, with 323 implications for complex traits affecting muscle tissue. 
with genes that are relevant in metabolic phenotypes, such as cholesterol levels 66, 67 . In the GTEx 329 data, rs4731702 was not quite statistically significant as a cis-eQTL in adipose -subcutaneous in 330 the GTEx data (P ≤ 8.1 x 10 -5 , where the FDR ≤ 0.05 significance threshold is P ≤ 5.7 x 10 -5 ).
331
Adipose -visceral did not have any significant cis-eQTLs at this locus. However, we identified 332 two variants, rs13234269 ( Fig. 5a) However, the absolute value effect sizes of rs13234269 across 14,105 genes shared in the two 343 adipose tissues showed poor correlation across the two tissues (R 2 = 0.11; Fig. 5d ). KLF14 is a maternally expressed transcription factor in an imprinted locus, and the MuTHER 345 study included only females. In GTEx data, both tissues included moderate evidence of sex- Genotype data from the GTEx v6 release are available in dbGaP (study accession
